CClinicalTrials.gg
CompletedNCT06274307Updated Mar 24, 2025

Efficacy of Transversus Abdominis Plane Block

An interventional study of Transversus abdominis plane block in Anesthesia, Local, sponsored by Justin Hruska. Completed at 2 sites in United States. Open to female participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-24.

Sponsored by Justin Hruska · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2023, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
Female
01

Study summary

This study aims to assess the efficacy of Transversus Abdominus Plane (TAP) blocks, a well-established anesthetic technique, to decrease the amount of post-operative pain in patients who undergo minimally invasive gynecologic surgeries. During minimally invasive gynecologic surgeries, the abdomen is inflated with pressurized air for visualization purposes and released at the end of the surgery. Traditionally, TAP blocks are performed by injecting long-acting local anesthetic agents under ultrasound guidance into the abdominal wall after abdominal surgery after the air has been emptied from the abdomen for additional anesthetic coverage post-operatively. This study proposes a novel approach: that performing TAP blocks while the abdomen is still insufflated will result in better post-operative pain outcomes as compared to the traditional method.

Read the detailed description

Background

Every year 15 million laparoscopic procedures are performed globally, with 4,800,000 or 32% of procedures performed in the U.S. alone. This minimally invasive procedure is one of the most common surgical procedures in the United States. Approximately 350,000 or half of all bilateral tubal sterilizations are performed laparoscopically; almost two-thirds of the 600,000 hysterectomies are performed via laparoscopy. Laparoscopy is also commonly used for diagnostic purposes, and to perform other common procedures such as treatment for endometriosis and lysis of adhesions. During laparoscopic gynecologic surgeries, the surgical team will have the abdomen inflated with pressurized carbon dioxide for surgical visualization purposes which is then released at the end of the surgical procedure. For many laparoscopic procedures, a transversus abdominis plane block (TAP) block using a long-acting local anesthetic is used to manage pain performed outside the OR, more for logistical ease, traditionally this block is performed outside the operating room setting, in the post-operative period on a non- insufflated abdomen under ultrasound guidance.

Rationale for conducting the research. This study has two major aims; 1) to determine whether post-operative TAP blocks performed in an insufflated abdomen will result in more optimal postoperative pain control compared to TAP blocks performed in the traditional method in a non-insufflated abdomen and 2) to observe if performing the TAP block in a insufflated abdomen will be more clinically efficient to perform than the traditional method performed in a non-insufflated abdomen. The study hypothesis is that the study group receiving the TAP block the insufflated abdomen will have more optimal postoperative pain control, requiring less adjuvant pain medication as compared to the participants receiving the control intervention. Additionally, we hypothesize that the proceduralist will be able to perform a TAP block in less time with and with few attempts in the insufflated compared to the non- insufflated abdomen group due to better visualization of the anatomical planes from insufflation of the abdominal area. The results of this study may add additional clinically effective practice guidelines for both regional anesthesia and acute pain management relating to laparoscopic gynecological procedures. Furthermore, TAP blocks performed under insufflation may provide a viable method for decreasing opioid use and reducing potential opioid dependence in patients following surgical intervention.

02

Conditions studied

  • Anesthesia, Local

Keywords

  • Transversus abdominal-plane block
  • Pain managment
  • Ultrasound
03

In context

Lead sponsor

This is the only study on the registry with Justin Hruska as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female gynecological patients between 18 years and 85 years consented and scheduled for an obstetrics/gynecology laparoscopic procedure.
  • Consent received to receive a TAP block.

Exclusion criteria

Exclusion Criteria:

  • Patients who are not proficient in the English language or cannot consent
  • Patients who have an allergy to local anesthetics (amides)
  • Patients with subcutaneous emphysema
  • Patients whose surgical procedures require incisions above the umbilicus
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
106 participants (actual)

Study arms

  • Active comparator
    Active Comparator: Transversus abdominis plane (TAP) block performed in operating room

    The treatment group will have a transversus abdominis plane (TAP) block performed prior to closing surgical port sites post-operatively in an insufflated abdomen in the operating room (OR). The local anesthetic used for the TAP block will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% divided equally bilaterally. Each study participant will receive standard post-operative pain medication orders of morphine 2mg q5mins times 4 doses followed by hydromorphone. 0.5mg q10mins times 4 doses.

    Procedure: Transversus abdominis plane block

  • Active comparator
    Transversus abdominis plane (TAP) block performed in PACU

    The treatment group will have a transversus abdominis plane (TAP) block performed post-operatively after the patient has been transferred from the Operating Room to the Post Anesthesia Care Unit (PACU). The local anesthetic used for the TAP block will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% divided equally bilaterally. Each study participant will receive standard post-operative pain medication orders of morphine 2mg q5mins times 4 doses followed by hydromorphone. 0.5mg q10mins times 4 doses

    Procedure: Transversus abdominis plane block

Interventions

  • ProcedureTransversus abdominis plane block

    A transversus abdominis plane block (TAP) block using a long-acting local anesthetic is used to manage pain during the intermediate (12-24hr) post-operative period following laparoscopic abdominal surgeries. Drug: The local anesthetic to be used in this specific intervention will be 30 to 40ml of Ropivacaine 0.375%, not to exceed a max dose of 3mg/kg of 0.375% and divided equally bilaterally.

06

What researchers measure

Primary outcomes

  1. Time to perform TAP Block

    Time taken to successfully perform the TAP block. Defined as the time from initial placement of ultrasound probe on the skin to the completion of the block on the contralateral side.

    Time frame: Within 10 minutes of starting procedure.

  2. TAP block attempts

    The number of attempts taken to sucessfully perform the TAP block.

    Time frame: Within 10 minutes of starting procedure.

  3. Pain Score Visual Analog Scale (VAS) 0 Hours Post Surgery

    Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest

    Time frame: 0 hours following TAP block]

  4. Pain Score Visual Analog Scale (VAS) 1 Hours Post Surgery

    Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest

    Time frame: 1 hour following TAP block]

  5. Pain Score Visual Analog Scale (VAS) 2 Hours Post Surgery

    Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest

    Time frame: 2 hours following TAP block]

  6. Pain Score Visual Analog Scale (VAS) 4 Hours Post Surgery

    Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest

    Time frame: 4 hours following TAP block]

  7. Pain Score Visual Analog Scale (VAS) 24 Hours Post Surgery

    Pain score on an 11-point (0 - no pain to 10 - worst imaginable pain) Visual Analog Scale (VAS) at rest

    Time frame: 24 hours following TAP block]

  8. Postoperative Opioid Consumption

    Patient opioid consumption in the 24 hours post TAP block

    Time frame: 24 hours post operative period

  9. Ease of performing TAP Block-anatomical plane visualization

    The anatomical planes were clearly visualized and identified. Survey of operator - Likert Score

    Time frame: Within 10 minutes of starting procedure

  10. Ease of performing TAP Block-performance efficacy

    The approach optimized the efficacy of the block. Survey of operator- Likert score

    Time frame: Within 10 minutes of starting procedure

  11. Patient satisfaction

    Patient satisfaction with analgesia score (0 to 100%)

    Time frame: 24-hours post operative period

07

Study locations

2 sites
  • Detroit Medical Center Detroit Receiving Hospital
    Detroit, Michigan 48201, United States
  • Detroit Medical Center, Harper University Hospital
    Detroit, Michigan 48201, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06274307
Lead sponsor
Justin Hruska
Responsible party
Justin Hruska (Principal Investigator, Wayne State University) — Sponsor-investigator
First posted
Feb 23, 2024
Start date
Jun 22, 2023
Primary completion
Jan 1, 2025
Completion
Mar 1, 2025
Last update
Mar 24, 2025

Study contacts

Justin Hruska, MD
principal investigator · Wayne State University/Detroit Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion